Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson and one of the world’s leaders in oncology, is focused on harnessing the most compelling science with the aim of intercepting, preventing, treating, and ultimately curing cancer. Working toward t...
Research & Development. Creativity & Fresh Ideas. Science & Solutions. Collaboration is in our DNA. We know... Partner with Us We are committed to partnering with those whose innovative thinking will bring new and creative solutions to the field of medicine. ...
Our research pipeline is rich with transformational science reflecting our unique approach to innovation. See More > R&D Data Science Using data science and digital health to reimagine the discovery and development of medicines to advance our mission of bringing transformative therapies to patients...
s RSV adult vaccine program is part of a broader effort to make strategic choices for its pipeline and research and development (R&D) investments to focus on medicines with the greatest potential benefit to patients. The Company remains committed to investing in internal discovery, development and ...
Janssen continues to live up to our long-standing commitment of working tirelessly to bring truly transformational therapies to patients worldwide," said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. "With this new collaboration we ...
intellectual property to discover, research, develop, manufacture and commercialize fully human antibody therapeutics with a common light chain and other biological therapeutics for an unlimited number of drug targets and indications. The agreement was facilitated by Johnson & Johnson Innovation LLC. ...
‘pipeline in a pathway,’” said Mathai Mammen, M.D., Ph.D., Global Head of Janssen Research & Development,Johnson & Johnson. “We are excited about the significant potential to expand on Momenta’s excellent progress in rare diseases,...
we see a real opportunity to create an entire 'pipeline in a pathway,'" saidMathai Mammen, M.D., Ph.D., Global Head of Janssen Research & Development, Johnson & Johnson. "We are excited about the significant potential to e...
He partners with market researchers within GCSO Therapy Area teams to drive cutting-edge research to support development decisions for compounds in Janssen’s R&D pipeline. His focus includes providing guidance on reliable methods for unearthing rich patient emotional and rational insights to fuel asset...
Janssen Germany Select region: EMEA Enter Social media icon: Enter Social media background image: Enter Social media hastag or short description: @Janssen_Presse Enter Social media links: https://twitter.com/janssen_presse globalval: 2 Country Cluster: ...